Full video captions will be made available soon.
Thursday, June 18, 2020
Converts to: 2pm Pretoria; 3pm Addis Ababa; 7pm Bangkok
About the webinar
To know the actual prevalence of COVID-19, testing must be scaled up in all countries. However, testing capacity remains limited globally and serological tests that have the potential to determine when people can safely return to normal social and economic activities and donate convalescent plasma are yet to be validated. Under these circumstances, what are the best practices in testing?
Dr. Ahmed Ogwell Ouma, Deputy Director, Africa CDC
Dr. Janet Robinson, Director, Laboratory Sciences, FHI 360